Full Product Name
BTBD9 (KIAA1880, BTB/POZ Domain-containing Protein 9, FLJ32945, MGC120517, MGC120519, MGC120520)
Product Synonym Names
Anti -BTBD9 (KIAA1880, BTB/POZ Domain-containing Protein 9, FLJ32945, MGC120517, MGC120519, MGC120520)
Product Gene Name
anti-BTBD9 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Immunogen Sequence
MCRALLYGGM RESQPEAEIP LQDTTAEAFT MLLKYIYTGR ATLTDEKEEV LLDFLSLAHK YGFPELEDST SEYLCTILNI QNVCMTFDVA SLYSLPKLTC MCCMFMDRNA QEVLSSEGFL SLSKTALLNI VLRDSFAAPE KDIFLALLNW CKHNSKENHA EIMQAVRLPL MSLTELLNVV RPSGLLSPDA ILDAIKVRSE SRDMDLNYRG MLIPEENIAT MKYGAQVVKG ELKSALLDGD TQNYDLDHGF SRHPIDDDCR SGIEIKLGQP SIINHIRILL WDRDSR
SYSY FIEVSMDELD WVRVIDHSQY LCRSWQKLYF PARVCSGDGV SLWCPLWSRT PELKQSSLLG LPKCRYIRIV GTHNTVNKIF HIVAFECMFT NKTFTLEKGL IVPMENVATI ADCASVIEGV SRSRNALLNG DTKNYDWDSG YTCHQLGSGA IVVQLAQPYM IGSIRLLLWD CDDRSYSYYV EVSTNQQQWT MVADRTKVSC KSWQSVTFER QPASFIRIVG THNTANEVFH CVHFECPEQQ SSQKEENSEE SGTGDTSLAG QQLDSHALRA PSGSSLPSSP GSNSRSPNRQ HQ
Chromosome Location
Chromosome: 6; NC_000006.11 (38136227..38608202, complement). Location: 6p21
3D Structure
ModBase 3D Structure for Q96Q07
Specificity
Recognizes human BTBD9.
Purity/Purification
Serum
Serum
Form/Format
Supplied as a liquid.
Immunogen
Full length human BTBD9, aa1-582 (AAI01358.1).
Preparation and Storage
May be stored at 4 degree C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20 degree C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Other Notes
Small volumes of anti-BTBD9 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-BTBD9 antibody
This locus encodes a BTB/POZ domain-containing protein. This domain is known to be involved in protein-protein interactions. Polymorphisms at this locus have been reported to be associated with susceptibility to Restless Legs Syndrome and may also be associated with Tourette Syndrome.
Product Categories/Family for anti-BTBD9 antibody
Antibodies; Abs to Proteins
Applications Tested/Suitable for anti-BTBD9 antibody
Immunoprecipitation (IP)
Application Notes for anti-BTBD9 antibody
Suitable for use in Immunoprecipitation.
NCBI/Uniprot data below describe general gene information for BTBD9. It may not necessarily be applicable to this product.
NCBI Accession #
NP_443125.1
[Other Products]
NCBI GenBank Nucleotide #
NM_052893.1
[Other Products]
UniProt Primary Accession #
Q96Q07
[Other Products]
UniProt Secondary Accession #
Q494V9; Q494W1; Q96M00[Other Products]
UniProt Related Accession #
Q96Q07[Other Products]
Molecular Weight
69,188 Da[Similar Products]
NCBI Official Full Name
BTB/POZ domain-containing protein 9 isoform a
NCBI Official Synonym Full Names
BTB (POZ) domain containing 9
NCBI Official Symbol
BTBD9??[Similar Products]
NCBI Official Synonym Symbols
dJ322I12.1
??[Similar Products]
NCBI Protein Information
BTB/POZ domain-containing protein 9
UniProt Protein Name
BTB/POZ domain-containing protein 9
Protein Family
BTB/POZ domain-containing protein
UniProt Gene Name
BTBD9??[Similar Products]
UniProt Synonym Gene Names
KIAA1880??[Similar Products]
UniProt Entry Name
BTBD9_HUMAN
NCBI Summary for BTBD9
This locus encodes a BTB/POZ domain-containing protein. This domain is known to be involved in protein-protein interactions. Polymorphisms at this locus have been reported to be associated with susceptibility to Restless Legs Syndrome and may also be associated with Tourette Syndrome. Alternatively spliced transcript variants have been described. [provided by RefSeq, Aug 2011]
UniProt Comments for BTBD9
Tissue specificity: Highly expressed in kidney and moderately expressed in all other ***** and fetal tissues. Moderately expressed in all specific brain regions examined. Ref.1
Involvement in disease: Restless legs syndrome 6 (RLS6) [MIM:611185]: A neurologic sleep/wake disorder characterized by uncomfortable and unpleasant sensations in the legs that appear at rest, usually at night, inducing an irresistible desire to move the legs. The disorder results in nocturnal insomnia and chronic sleep deprivation. The majority of patients also have periodic limb movements in sleep, which are characterized by involuntary, highly stereotypical, regularly occurring limb movements that occur during sleep.Note: Disease susceptibility may be associated with variations affecting the gene represented in this entry. Ref.6 Ref.7
Sequence similarities: Contains 1 BACK (BTB/Kelch associated) domain.Contains 1 BTB (POZ) domain.
Sequence caution: The sequence BAB67773.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened.
Research Articles on BTBD9
1. There was a statistically significant association between the variant rs9296249 of the BTBD9 gene and the TS phenotype
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
